Skip to content
OpenCapital
Get started

Intuitive Surgical ISRG Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value

Other financials

Income statement

See full
Revenue$2.8B+23.0%
Gross profit$1.8B+25.6%
Operating income$855.3M+47.9%
Net income$821.5M+17.6%
EPS (diluted)$2.28+18.8%

Balance sheet

See full
Cash & equivalents$2.1B-21.6%
Total equity$17.5B+2.2%
Total assets$20.1B+4.6%

Cash flow

See full
Operating cash flow$911.9M+56.8%
CapEx$103.3M-11.4%
Free cash flow$808.6M+73.9%

Valuation

See full
Market cap$144.07B-7.7%
P/E48.4×-14.7×
P/S13.6×-4.3×

Profitability

See full
Gross margin66.3%-0.8pp
Operating margin30.5%+2.3pp
Net margin28.2%-0.3pp

Returns & leverage

See full
Return on equity17.2%+1.3pp
Debt / equity0×0.0×
Current ratio4.6×-0.4×

Where this comes from

Reported directly by Intuitive Surgical in its filing.

Tagged under the XBRL concept isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue.

The official record: Intuitive Surgical’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value?
Intuitive Surgical (ISRG) reported cash and cash equivalents and debt securities, available-for-sale, fair value of $7.98B in Q1 2026.
How has Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value changed year-over-year?
Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value decreased by 12.3% year-over-year, from $9.1B to $7.98B.
What is the long-term trend for Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value?
Over 5 years (2020 to 2025), Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value has grown at a 5.6% compound annual growth rate (CAGR), from $6.87B to $9.03B.